Shree Ganesh Remedies
420.05
-21.80(-4.93%)
Market Cap₹567.20 Cr
PE Ratio31.38
IndustryHealthcare
Company Performance:
1D-4.93%
1M-17.99%
6M-19.34%
1Y-39.84%
5Y+57.59%
View Company Insightsright
More news about Shree Ganesh Remedies
19May 25
Shree Ganesh Remedies Reports Mixed Q4 Results with Profit Growth and Revenue Decline
Shree Ganesh Remedies' Q4 results show a mixed performance. Net profit increased to ₹66.00 crore from ₹54.00 crore in Q3, but decreased from ₹126.00 crore year-over-year. Revenue declined to ₹244.00 crore from ₹373.00 crore in the previous year. EBITDA fell to ₹9.90 crore from ₹16.90 crore, with EBITDA margin dropping to 40.44% from 45.40% year-over-year.
 no imag found
Shree Ganesh Remedies
420.05
-21.80
(-4.93%)
1 Year Returns:-39.84%
Industry Peers
Sun Pharmaceutical
1,757.20
(-2.03%)
Divis Laboratories
5,947.00
(-0.84%)
Torrent Pharmaceuticals
4,220.20
(-1.06%)
Dr Reddys Laboratories
1,254.90
(-2.09%)
Lupin
2,313.90
(-0.90%)
Cipla
1,224.20
(-1.46%)
Zydus Life Science
871.20
(-2.84%)
Mankind Pharma
2,005.80
(-1.62%)
Aurobindo Pharma
1,304.40
(-0.75%)
Alkem Laboratories
5,299.00
(-0.85%)